Case report
A 40-year-old white man was referred to our clinic for an asymptomatic pigmented patch on his right cheek for 2 months that did not have seasonal variation. Clinically, the lesion was a slightly and irregularly pigmented patch of about 6 × 3 cm (Fig 1). The patient had no history of trauma or sunburn; no drugs were taken in the previous months.
Fig 1.
A, Clinical evaluation found a patch of about 6 × 3 cm, slightly and irregularly pigmented on the right cheek. B, Dermoscopic pattern with diffuse peppering, hyperpigmented follicular opening (yellow arrows), and some hair follicles with central black dots (isobar sign) (red arrows).
Dermoscopic examination (Fig 1) found diffuse peppering, some hair follicles with central black dots (also known as isobar sign) and some hyperpigmented follicular openings; all these features suggested a diagnosis of lentigo maligna melanoma.
A reflectance confocal microscopy (RCM) evaluation found spongiotic epidermis with exocytosis at the granulosum/spinosum layer and a mixed cell population composed of numerous pleomorphic cells (with enlarged refractile cytoplasm and evident dark nucleus) corresponding to melanocytes. These melanocytes were associated with plump, bright round to polygonal non-nucleated cells corresponding to melanophages and lymphocytes located at dermoepidermal junction level (lichenoid disposition). Small bright stellate cells corresponding to inflammatory cell infiltration were observed with adnexal disposition. Horizontal blood vessels, aberrant extracellular matrix with thickening of collagen bundles, and mixed inflammatory infiltrate with lymphocytes and melanophages were seen in papillary dermis (Fig 2). No pagetoid cells were detected.
Fig 2.
RCM evaluation (mosaic 1 × 1 mm). A, Spongiotic epidermis (yellow circle) with exocitosis (yellow arrows) at granulosum/spinosum layer. B, Pleomorphic cells with enlarged refractile cytoplasm and evident nucleus corresponding to melanocytes (red arrows), associated with plump, bright round to polygonal non-nucleated cells corresponding to melanophages (blue arrows) and inflammatory infiltrate (yellow arrows) located at the dermoepidermal junction level. C, Papillary dermis showed horizontal blood vessels, aberrant extracellular matrix with thickening of collagen bundles, and lichenoid inflammatory infiltrate with periadnexal disposition mixed with some melanophages. D, Histopathologic analysis of PALP: at dermoepidermal junction focal and slight elongated ridges (hematoxylin-eosin, original magnification ×100). E, At the dermal level, small nests or isolated melanocytic cells together with melanophages and focal lichenoid inflammatory infiltrates with Civatte bodies. A prominent inflammatory infiltrate, composed by mixture of lymphocytes and histiocytes placed in periadnexal and perifollicular areas. Chronic actinic damage (solar elastosis) was also found (hematoxylin-eosin, original magnification ×200). F, Immunohistochemistry stain (MART-1 stain): strong Melan-A positivity (original magnification ×200). (D and E, Hematoxylin eosin stain; F, MART-1 stain; Original magnifications: D, ×100; E and F, ×200.)
A punch biopsy was performed for histopathologic confirmation and found focal and slightly elongated ridges. At the dermoepidermal junction, melanocytes either isolated or aggregated in small nests were observed along with a focal lichenoid inflammatory cell infiltrate with colloid bodies corresponding to Civatte bodies. At the dermal level, chronic actinic damage (solar elastosis) and melanophages were also found. A prominent inflammatory infiltrate was seen composed by mixture of lymphocytes and hystiocytes placed in periadnexal and perifollicular areas (Fig 2). Immunohistochemistry staining found a strong Melan-A positivity (MART-1) corresponding to melanocyte antigen recognized by autologous cytotoxic T cells (Fig 2). Pigmented actinic lichen planus (PALP) was diagnosed.
The patient was treated with diflucortolone valerate cream (once daily for 3 months) and daily photoprotection using sunscreen cream with organic broadband anti–ultraviolet (UV) A and anti-UVB filters (sun protection factor (SPF) 50 and UVA-SPF 30) for 3 months. A clinically optimal response was achieved at the end of the treatment showing a reduction of pigmentation (Fig 3) as confirmed by imaging evaluation. Dermoscopy found a disappearance of isobar signs and a reduction of peppering (Fig 3). RCM examination found a conspicuous reduction of all pleomorphic cellularity (Fig 3). We decided to monitor therapeutic response with dermoscopy and in vivo RCM, avoiding punch biopsy with subsequent scar formation.
Fig 3.
Clinical improvement of the lesions 3 (A) and 6 (B) months after starting topical corticosteroids and sunscreen. C, Dermoscopic improvement after 6 months of topical corticosteroids: disappearing of peppering, irregular pigmentation, and isobar sign. D, RCM evaluation after 3 months of steroid therapy. Mosaic (3.5 × 3.5 mm) shows a clear improvement of inflammatory infiltrate.
Discussion
Actinic lichen planus (ALP) is thought to be a rare photosensitive subtype of lichen planus, also known as lichen planus subtropicus, lichen planus tropicus, summertime actinic lichenoid eruption, lichen planus atrophicus annularis, and lichenoid melanodermatosis.1
ALP generally occurs in children and young adults of Middle Eastern countries,1, 2, 3 arising predominantly during spring and summer.4 The etiology is still unknown; however, natural and artificial UV radiation appears to be the major precipitating factor as reported in literature.5, 6, 7
Lesions occur mainly on sun-exposed areas, usually forehead, face, and neck or dorsum of fingers and hands.1 It is clinically quite heterogeneous, and 4 morphologic patterns were described: annular, dyschromic, plaquelike type, and pigmented variants.1, 2, 5
The pigmented form (PALP), also called melasmalike type, is characterized by gray to brown or black patches located on sun-exposed areas, such as face and neck, ranging in size between 0.5 to 5 cm. Unlike classic lichen planus, Koebner phenomenon and mucosal or nail involvement are not common in the actinic variant. Pruritus is minimal or absent.6
The dermoscopic feature of PALP is a diffuse peppering pigment pattern arising on a brown background that is seen in the early phase of PALP8 fading in color without other identifiable features (absence of Wickham striae pattern and vascular patterns); hyperpigmented follicular openings and isobar sign may be present.
Histopathologic examination is similar to that of the classic lichen planus: hyperkeratosis, hypergranulosis, a bandlike lymphocytic infiltrate, and Civatte bodies are usually present. Furthermore, PALP presents a variable degree of solar elastosis and has a tendency to thinning of the epidermis at the center of the lesion9 with striking pigment incontinence in the upper dermis and melanophages.1 Epidermal atrophy may be prominent.5
Differential diagnoses include discoid lupus erythematosus, annular granuloma, melasma, secondary syphilis, fixed drug eruption, polymorphus light eruption, and erythema discromicum perstans.1, 9
Treatment strategies first call for use of sunscreen and avoiding sun exposure. Topical10 or intralesional glucocorticoids and hydroxychloroquine11 have been used. Some cases improved with acitretin in combination with topical steroids7 or cyclosporine for the refractory cases.6, 12
To our knowledge, this is the first report in literature of a PALP described with in vivo RCM. RCM has allowed the definition of the benign nature of these lesions, characterized by a mixed cellular population (inflammatory, melanocytic cells, and melanophages) in the absence of atypical and pagetoid cells.
Even though histologic examination remains the gold standard in the diagnosis and differential diagnosis of pigmented and nonpigmented skin lesions, in our patient, the strong immunohistochemistry MART-1 positivity together with a dermoscopic pattern mimicking lentigo maligna melanoma could have led to a misdiagnosis of melanoma.
MART-1 is a melanocyte marker, most commonly used in addition to S-100 protein and HMB-45 stain, in the immunohistochemical identification of malignant melanoma.13, 14, 15
As reported in literature, some cases of pigmented lesion on sun-damage skin may be accompanied by inflammatory reaction associated with pseudomelanocytic nests at the dermoepidermal junction that simulate small complexes of melanocytes, with strong MART-1 positivity, thereby resulting in a wrong diagnosis of melanoma.15
Maize et al16 suggested that pseudomelanocytic nests correspond to keratinocytes and other nonmelanocytic cells. Despite this, DeMartini et al17 reported in 2005 that no Melan-A∖MART-1–positive pseudonests were found in their 132 cases of lichen planus, and the authors emphasize that a strictly clinical and pathologic correlation is needed because the nonspecific pseudonests staining by Melan-A∖MART-1 is an uncommon occurrence in lesions with lichenoid inflammation.17
Therefore, only the integration between clinical history and imaging (dermoscopy and RCM) can help better understand the histologic findings in case of Melan-A/MART-1 positivity. In our report, RCM was useful in distinguishing this as a benign lesion, avoiding invasive and unnecessary skin biopsies and preserving a good cosmetic outcome.
Footnotes
Funding sources: None.
Conflicts of interest: None disclosed.
References
- 1.Shanna B., Joy Kunishige B.S., Francisco A., Hassanein A.M. Lichen planus actinicus. Cutis. 2003;72:377–381. [PubMed] [Google Scholar]
- 2.Salman S.M., Kibbi A.G., Zaynoun S. Actinic lichen planus. J Am Acad Dermatol. 1989;2:226–231. [PubMed] [Google Scholar]
- 3.Zanca A., Zanca A. Lichen planus actinicus. Int J Dermatol. 1978;17:506–508. doi: 10.1111/j.1365-4362.1978.tb06188.x. [DOI] [PubMed] [Google Scholar]
- 4.Isaacson D., Turner M.L., Elgart M.L. Summertime actinic lichenoid eruption (lichen planus actinicus) J Am Acad Dermatol. 1981;4:404. doi: 10.1016/s0190-9622(81)70038-0. [DOI] [PubMed] [Google Scholar]
- 5.Gene H.K., Mikkilineni R. Lichen planus actinicus. Dermatol Online J. 2007;13:13. [PubMed] [Google Scholar]
- 6.Van der Schroeff J.G., Schroeff J.G., Schothorst A.A., Kanaar P. Induction of actinic lichen planus with artificial light sources. Arch Dermatol. 1983;119:498. doi: 10.1001/archderm.119.6.498. [DOI] [PubMed] [Google Scholar]
- 7.Jansen T., Gambichler T., von Kobyletzki L., Altmeyer P. Lichen planus actinicus treated with acitretin and topical corticosteroids. J Eur Acad Dermatol Venereol. 2002;16:174–175. doi: 10.1046/j.1468-3083.2002.00392_3.x. [DOI] [PubMed] [Google Scholar]
- 8.Güngör S., Topal I., Göncü E. Dermoscopic patterns in active and regressive lichen planus and lichen planus variants: a morphological study. Dermatol Pract Concept. 2015;5:45–53. doi: 10.5826/dpc.0502a06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Elder D.E., Elenitsas R., Johnson B.L., Murphy G.F., Xu X. 10th edition. Lippincott Williams & Wilkins; Philadelphia, Pa, USA: 2008. Lever's Histopathology of the Skin. [Google Scholar]
- 10.Elkpo F., Cibull T., Kaminska E.C. Violaceous eruption on the head and extremities. JAMA Dermatol. 2015;151:1121–1122. doi: 10.1001/jamadermatol.2015.2104. [DOI] [PubMed] [Google Scholar]
- 11.Ramirez P., Feito M., Sendagorta E., González-Beato M., De Lucas R. Childhood actinic lichen planus: successful treatment with antimalarials. Australas J Dermatol. 2012;55:10–13. doi: 10.1111/j.1440-0960.2010.00695.x. [DOI] [PubMed] [Google Scholar]
- 12.Gallo L., Ayala F., Ayala F. Relapsing lichen actinicus successfully treated with cyclosporine. J Eur Acad Dermatol Venereol. 2008;2:370–371. doi: 10.1111/j.1468-3083.2007.02325.x. [DOI] [PubMed] [Google Scholar]
- 13.Wiltz K., Quereshi H., Patterson J., Mayes D.C., Wick M.R. Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions. J Cutan Pathol. 2007;34:601–605. doi: 10.1111/j.1600-0560.2006.00673.x. [DOI] [PubMed] [Google Scholar]
- 14.Shabrawi-Caelen L., Kerl H., Cerroni L. Melan-A: Not a helpful marker in distinction between melanoma in situ on sun-damage skin and pigmented actinic keratosis. Am J Dermatopathol. 2004;26:364–366. doi: 10.1097/00000372-200410000-00003. [DOI] [PubMed] [Google Scholar]
- 15.Beltraminelli H., El Shabrawi-Caelen L., Kerl H., Cerroni L. Melan-A-Positive “Pseudomelanocytic nests”: A pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damage skin. Am J Dermatopathol. 2009;31:305–308. doi: 10.1097/DAD.0b013e31819d3769. [DOI] [PubMed] [Google Scholar]
- 16.Maize J.C., Resneck J.S., Shapiro P.E., McCalmont T.H., LeBoit P.E. Ducking stray” magic Bullets”: a melan-a alert. Am J Dermatopathol. 2003;25:162–165. doi: 10.1097/00000372-200304000-00013. [DOI] [PubMed] [Google Scholar]
- 17.DeMartini C.S., Dalton M.S., Ferringer T., Elston D.M. Melan-A/MART-1 positive “pseudonests” in lichenoid inflammatory lesions: an uncommon phenomenon. Am J Dermatopathol. 2005;27:370–371. doi: 10.1097/01.dad.0000157446.60118.d9. [DOI] [PubMed] [Google Scholar]



